Unlike in the general population, women with stage 5 chronic kidney disease (CKD) do not have a sex-based survival advantage ...

FDA approves pembrolizumab and enfortumab vedotin for neoadjuvant and adjuvant treatment of cisplatin-ineligible muscle-invasive bladder cancer.

Inflation-adjusted annual cost of U.S. medical school attendance increased from $51,400 to $71,000 between 2008 and 2020.

Researchers explored the relationship between positive mental health literacy, job crafting, and job well-being in palliative care nurses. Job crafting mediates the relationship between positive ...

Both T1D and T2D independently associated with SCD, with the greatest risk difference seen for younger individuals.

(HealthDay News) — One dose of bivalent or nonavalent human papillomavirus (HPV) vaccine is noninferior to two doses for protecting against HPV16 and HPV18 infection, according to a study published ...

A diagnosis of polycystic kidney disease does not preclude good nutrition. Clinicians should guide patients toward safer and healthier eating.

(HealthDay News) — The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an adjunct to lifestyle modification versus placebo for ...

In this cross-sectional analysis, researchers aimed to characterize the NIH trials affected by grant terminations under the Trump administration. More than 74,000 individuals were enrolled in active ...

Having a longer travel time to their treatment facility improves survival in prostate cancer patients, according to a recent study.

“We need organizational strength and stability at the agency,” John Crowley, CEO of the biotechnology trade group BIO, told STAT News. “This constant turmoil is undermining America’s leadership in ...

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.